Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progestogens and their relation to vascular thrombosis.
Oral contraceptives (OC) have been shown to induce in some women antiethinylestradiol antibodies which may be detected as circulating immune complexes by precipitation in ammonium sulphate at 25% saturation (CIC.AS). A reevaluation of the presence of CIC.AS in 644 women either receiving sex steroid hormones or not was made, and the respective role of estrogens and progestogens investigated, together with the influence of the dose. The study confirmed that CIC.AS levels were significantly different in controls (442 +/- 246 micrograms/ml serum), healthy gonadal hormone users (754 +/- 700 micrograms) and users with thrombosis (1331 +/- 1099 micrograms/ml). These results indicated that: 1. CIC.AS could be induced by synthetic estrogens as well as progestogens, but not by non-synthetic hormones; 2. the induction of CIC.AS seemed poorly dose-related, and 3. was not correlated with the duration of use; 4. in reactive women, high CIC.AS levels occurred as soon as 3 weeks after the beginning of synthetic gonadal hormones use, persisted throughout treatment and decreased slowly when discontinued; 5. in women with thrombosis CIC.AS were more frequently detected (64.7%) than in healthy users (32.2%) P less than 0.001. The importance of the immunologic changes as a risk factor in thrombosis in OC users was evaluated in comparison with other predisposing factors and tobacco smoking.
D000293:Adolescent; D000328:Adult; D000375:Aging; D000936:Antigen-Antibody Complex / Q000032:analysis*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D004306:Dose-Response Relationship, Immunologic; D045166:Estradiol Congeners / Q000009:adverse effects / Q000276:immunology; D004967:Estrogens / Q000009:adverse effects / Q000276:immunology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D045167:Progesterone Congeners / Q000009:adverse effects / Q000276:immunology*; D012306:Risk; D012907:Smoking; D013927:Thrombosis / Q000209:etiology* / Q000276:immunology
D000936:Antigen-Antibody Complex; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D045166:Estradiol Congeners; D004967:Estrogens; D045167:Progesterone Congeners